Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulindac in Smokers With Bronchial Dysplasia
NCT00368927Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2006
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sulindac in lung cancer, sponsored by National Cancer Institute. Started Aug 2006; status: completed.
02
Drugs
sulindac
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00368927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368927.